SMARCB1 and colorectal carcinoma: Recently, Ahadi et al. [10] reported loss of SMARCA4 expression in 13 (0.3%), loss of SMARCA2 expression in 59 (1.3%), and loss of SMARCB1 expression in 21 (0.4%) among 4508 consecutive resected CRC cases.